Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04036773 · ClinicalTrials.gov registry record · NA
Food Pharmacy at Oregon Health & Science University (OHSU) Knight Cardiovascular Institute (KCVI)
A NA study of Hyperlipidemias, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04036773: Completed NA study of Hyperlipidemias, sponsored by Oregon Health and Science University.
NCT04036773 is a NA study of Hyperlipidemias that has completed, run by Oregon Health and Science University. The registered enrollment target is 20 participants, below the 4,020-participant average among 21 other Hyperlipidemias trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04036773, a NA study of Hyperlipidemias, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants in the intervention group of this study will receive weekly home deliveries of fruit \& vegetables for 3 months. The primary objective of this study is to determine if increased access to fruits and vegetables leads to sustained dietary changes, measured through changes in the Healthy Eating Index (HEI). Secondary objectives are to determine whether increased fruit and vegetable access (increased HEI) ultimately leads to improved cardiovascular (CV) health indicators (e.g., body mass index, waist circumference, blood pressure, and levels of blood lipids and hemoglobin A1c).
Primary Outcome
The HEI uses a scoring system to evaluate a set of foods. The scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations from the Dietary Guidelines for Americans.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Fruit and vegetable deliveries
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2020-12-15 |
| Phase | NA |
What the finished NCT04036773 record still lists
NCT04036773 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 4,020-participant average among 21 other Hyperlipidemias trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Hyperlipidemias appearing as the primary indexed condition, and to 1 intervention - of which Fruit and vegetable deliveries is the first listed.
NCT04036773 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04036773 about?
NCT04036773 is a clinical study titled "Food Pharmacy at Oregon Health & Science University (OHSU) Knight Cardiovascular Institute (KCVI)". Participants in the intervention group of this study will receive weekly home deliveries of fruit \& vegetables for 3 months. The primary objective of this study is to determine if increased access to fruits and vegetables leads to sustained dietary changes, measured through changes in the Healthy E...
What is the current status of trial NCT04036773?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-10-14. Estimated completion is 2020-12-15.
What conditions does trial NCT04036773 study?
This clinical trial studies the following conditions: Hyperlipidemias.
What interventions are being tested in trial NCT04036773?
The interventions under investigation include: Fruit and vegetable deliveries (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04036773?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04036773 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperlipidemias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04036773's enrollment target sits among peer trials
20 18th of 21 higher than 3 of 21 other Hyperlipidemias trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperlipidemias trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Penn Medicine Healthy Heart
RECRUITING · NA
-
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
RECRUITING · NA
-
Social Needs Screening and Chronic Diseases Study (WE CARE)
RECRUITING · NA
-
Centralized Prescribing for Statins
ACTIVE NOT RECRUITING · NA
-
Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI